Quest Laboratories SME IPO Details, Financials, Valuation & Peers
Get everything you need to know about the Quest Laboratories IPO at IPOBase. Explore Quest Laboratories IPO details, including IPO dates, financial statements, valuation, peer comparison, and more.
Overview
Quest Laboratories Limited is a pharmaceutical company specializing in the manufacturing of a diverse range of pharmaceutical formulations. These formulations cover a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. Marketed under the trademark "Quest Laboratories Limited," these formulations cater to various medical needs and preferences, available in forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids.
Key Points:
- Laboratory Facilities: Equipped with advanced instruments such as HPLC, GC, FTIR, and UV spectrometry, Quest Laboratories' in-house laboratory conducts comprehensive tests and analyses. Professional staff ensures reliability and credibility in laboratory results and services, supporting product development, quality control, and regulatory compliance.
- Market Presence: Operating in twelve states and two union territories across India, Quest Laboratories serves both private sector and government institutions. The company has successfully secured government tender contracts, collaborating with major state and central government bodies.
- Product Portfolio and Innovation: Quest Laboratories continually expands its product portfolio through research and development of new pharmaceutical formulations. The in-house Department of Formulation Development, Quality Control, and Product Stability Studies ensures the creation and maintenance of high-quality pharmaceutical products, meeting regulatory standards and customer expectations.
Objects of the Issue
- Funding of capital expenditure towards purchase of Plant and Machineries for Expansion and Upgradation at the existing Manufacturing Facility situated at Dhar, Madhya Pradesh.
- Funding Working Capital Requirements of the Company
- General Corporate Purpose
IPO Details
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
| Fields | Details |
|---|---|
| IPO Dates | 15 May - 17 May 2024 |
| IPO Price Band | ₹ 93 - 97 per share |
| Fresh Issue | 44,49,600 Shares |
| Offer For Sale | NIL |
| Total IPO Size | ₹ 43.16 crore |
| Face Value | ₹ 10 |
| Listing On | NSE |
IPO Timeline
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
| Event | Date |
|---|---|
| IPO Opening Date | 15 May 2024 |
| IPO Closing Date | 17 May 2024 |
| Basis Of Allotment | 21 May 2024 |
| Refunds | 22 May 2024 |
| Demat Transfer | 22 May 2024 |
| IPO Listing Date | 23 May 2024 |
Financial Statements
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
| Period Ended | 31st March 2021 | 31st March 2022 | 31st March 2023 | Dec 2023 |
|---|---|---|---|---|
| Total Income | 30.44 | 59.54 | 61.87 | 62.18 |
| Total Expenses | 29.65 | 53.78 | 54.91 | 51.03 |
| Net Profit/Loss | 0.66 | 4.11 | 5.03 | 7.75 |
| NPM (*) | 2.16 | 6.90 | 8.16 | 12.48 |
| Total Assets | 18.40 | 34.80 | 46.65 | 58.69 |
| Total Liabilities | 12.51 | 24.80 | 31.63 | 35.92 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹cr)
Valuation
Uncover significant valuation metrics such as EPS (Earnings Per Share), ROE (Return on Equity), ROCE (Return on Capital Employed), D/E Ratio (Debt-to-Equity Ratio), Current Ratio, and EBITDA Margin. These key indicators offer insights into the company's financial standing and performance, aiding in informed investment decisions.
| Period Ended | 31st March 2021 | 31st March 2022 | 31st March 2023 | Dec 2023 |
|---|---|---|---|---|
| EPS | 0.61 | 3.81 | 4.66 | 7.18 |
| ROE (%) | 11.78 | 51.69 | 40.20 | 34.03 |
| ROCE (%) | 11.82 | 44.65 | 38.03 | 41.86 |
| D/E Ratio | 0.52 | 0.31 | 0.27 | 0.20 |
| Current Ratio | 1.10 | 1.17 | 1.25 | 1.42 |
| EBITDA MARGIN (%) | 4.67 | 10.87 | 12.69 | 19.47 |
* Compiled from DRHP/RHP for valuation purposes.
Peer Comparison
Compare key financial metrics with industry peers to gain valuable insights into the company's performance compared to its competitors.
| Name | Revenue | P/E | EPS | RoNW | NAV |
|---|---|---|---|---|---|
| Quest Laboratories Limited | 61.64 | 20.82 | 4.66 | 33.47 | 13.93 |
| Beta Drugs Limited | 157.87 | 66.43 | 19.57 | 19.55 | 100.12 |
| Alpa Laboratories Limited | 92.96 | 15.92 | 5.90 | 8.59 | 68.69 |
| Zenith Drugs Limited | 114.52 | 14.69 | 4.29 | 29.88 | 14.37 |
* Revenue in (₹cr), RoNW in (%), EPS, NAV in (₹). P/E ratio is based on the highest price from the IPO price band.
Subscription Data from NSE and BSE
| Investor Type | Subscribed |
|---|---|
| Qualified Institutional Buyer (QIB) | 57.2 |
| Non-Institutional Investor (NII/HNI) | 184.1 |
| Retail Individual Investor (RII) | 57.63 |
| Total | 85.26 |
* All figures represent multiples of the subscription. Check subscriptions for other ongoing issues here.
IPO Registrar
Bigshare Services Private Limited
Phone: +91 22-62638200
Email: ipo@bigshareonline.com
Website: www.bigshareonline.com
Company Promoters
- MR. ANIL KUMAR SABARWAL
- MS. TEJASWINI SABARWAL
Lead Managers
- SHRENI SHARES LIMITED
Company Address
Quest Laboratories Limited
Plot No. 45, Sector III, Pithampur Industrial Area, Pithampur, Dhar - 454775, Madhya Pradesh, India.
Phone: + 91 7292292374
Email: investors@questlabltd.com
Website: www.questlabltd.com
FAQs
- What is the issue size of the Quest Laboratories SME IPO?The Quest Laboratories SME IPO has an issue size of ₹ 43.16 crore. This includes a fresh issue of 44,49,600 Shares and an offer for sale (OFS) of NIL.
- What is the price band of the Quest Laboratories IPO?The price band for the Quest Laboratories IPO is ₹ 93 - 97 per share.
- What are the bidding dates for the Quest Laboratories IPO?The Quest Laboratories IPO will open for bidding on 15 May 2024 and close on 17 May 2024.
- What is the allotment date for the Quest Laboratories IPO?The allotment date for the Quest Laboratories IPO is 21 May 2024.
- What is the listing date for the Quest Laboratories IPO?The listing date for the Quest Laboratories IPO is 23 May 2024.
- What is the Quest Laboratories IPO grey market premium?The grey market premium (GMP) for the Quest Laboratories IPO is currently at ₹80, with an expected listing gain of approximately 82.47%. Remember, the grey market premium is not an official indicator, but it reflects market perception and demand for the IPO shares.